Clinical Trials Logo

Asthma clinical trials

View clinical trials related to Asthma.

Filter by:

NCT ID: NCT05533294 Completed - Asthma Clinical Trials

Study of ARO-RAGE in Healthy Subjects

Start date: November 29, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single- and multiple-ascending doses of ARO-RAGE Injection in normal healthy volunteers.

NCT ID: NCT05531370 Recruiting - Asthma Clinical Trials

Implementation of Evidence-based Breathing Retraining for Patients With Asthma in Region Zealand

EmBRAiZ
Start date: June 30, 2022
Phase: N/A
Study type: Interventional

This study aims to implement the evidence-based intervention breathing retraining into clinical care of patients with symptomatic asthma irrespective of asthma severity or comorbidities, and in a diverse multicentre setting to evaluate implementation outcomes. This will meet patients' needs and improve health and life situation in patients with uncontrolled asthma. Further, the study will evaluate implementation outcomes.

NCT ID: NCT05528679 Not yet recruiting - Asthma Clinical Trials

A Phase II Study of 610 in Participants With Severe Eosinophilic Asthma

Start date: September 2022
Phase: Phase 2
Study type: Interventional

This study will assess the efficacy and safety of 610 as an adjunctive therapy in adult subjects with severe eosinophilic asthma.

NCT ID: NCT05525169 Recruiting - Asthma Clinical Trials

Study of the Impact of Exposure to Outdoor and Indoor Pollutants in Patients With Asthma

EXAP
Start date: November 15, 2022
Phase:
Study type: Observational [Patient Registry]

The project is to measure exposure to outdoor and indoor air pollutants in asthma patients in order to show a possible association between variation in pollutant exposure and the occurrence of exacerbations in these patients

NCT ID: NCT05522439 Active, not recruiting - Clinical trials for Asthma With Eosinophilic Phenotype

A Study to Evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients With Eosinophil Phenotype

Start date: December 22, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients with Eosinophil Phenotype.

NCT ID: NCT05517096 Recruiting - Asthma in Children Clinical Trials

AmbuLatory Pediatric Asthma CAre

Start date: October 7, 2022
Phase: N/A
Study type: Interventional

The ALPACA study has a prospective randomized control interventional design, including a follow-up period to evaluate follow-up effects. The study is divided into two phases of 3 months using eHealth and observational monitoring.

NCT ID: NCT05505734 Active, not recruiting - Asthma Clinical Trials

A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma

Start date: September 2, 2022
Phase: Phase 3
Study type: Interventional

This is a US study comparing the efficacy and safety of BDA MDI [Budesonide/Albuterol Sulfate (BDA) metered dose inhaler (MDI)] with AS [Albuterol Sulfate] MDI, both are administered as needed for up to 12 months.

NCT ID: NCT05503342 Completed - Asthma Clinical Trials

Monitoring of Patients With Asthma Performed by a Clinical Pharmacist Using a Mobile Application

Start date: November 29, 2019
Phase: N/A
Study type: Interventional

Asthma is a chronic inflammatory disease that affects the lungs. In Brazil it is responsible for about 4 to 8 deaths per day. Pharmacotherapeutic follow-up programs for people with asthma have a positive impact on treatment adherence, as well as on education about the disease, helping patients in their self-management and recognition of their health status. The use of mobile applications that assist in the monitoring and self-management of people with asthma has been increasing significantly, but we do not have much information about their real impact on the control of the disease. Thus, the aim of this study is to evaluate the use of a mobile application in the monitoring and self-management of symptoms in adults with asthma in a pharmaceutical care program at a university outpatient clinic in São Paulo, Brazil.

NCT ID: NCT05501639 Completed - Asthma Clinical Trials

Exacerbation Risk in Asthma

Start date: May 14, 2021
Phase:
Study type: Observational

The purpose of this study is to conduct a comparative analysis of patients using Tiotropium in combination with Inhaled Corticosteroids (ICS) versus those that use long-acting β2-agonists (LABA) medication in combination with ICS.

NCT ID: NCT05500287 Completed - Asthma in Children Clinical Trials

Virtual Care In Pediatric Asthma

Start date: March 14, 2021
Phase: N/A
Study type: Interventional

The purpose of this study was to determine the impact of virtual care for children with asthma on the disease management and quality of life of children with asthma.